Article Text

Download PDFPDF
Drug-eluting balloon for instent restenosis
  1. Yin Chen1,
  2. Shilian Hu1,
  3. Lei Wu2
  1. 1Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China
  2. 2Department of neurology, Anhui Provincial Hospital, Hefei, Anhui, China
  1. Correspondence to Professor Shilian Hu, Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, No. 17, Lujiang Road, Hefei, Anhui 230001, China; hushilian{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor We read with interest the meta-analysis by Indermuehle A et al1 which reported that drug-eluting balloon (DEB) appears to show great promise for instent restenosis (ISR), and could reduce the risk for major adverse cardiac events compared with plain balloon angioplasty (BA) or implantation of drug-eluting stent (DES) in the treatment of ISR. Coronary ISR, happened after coronary stent implantation, continued to be a major problem. The authors raised a critical concern assessing the effectiveness of …

View Full Text


  • Contributors SH and YC designed the study; YC and LW extracted and analysed the data; YC and SH drafted the manuscript; YC, SH and LW revised the manuscript; SH and YC submitted the manuscript.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • PostScript
    Rahul Bahl Andreas Indermuehle Georg M Froehlich Alexandra J Lansky Guido Knapp Adam Timmis Pascal Meier